dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ruiz-Ortiz, Estíbaliz |
dc.contributor.author | Iglesias, Estíbaliz |
dc.contributor.author | Soriano, Alessandra |
dc.contributor.author | Bujan Rivas, Segundo |
dc.contributor.author | Español-Rego, Marta |
dc.contributor.author | Castellanos-Moreira, Raul |
dc.date.accessioned | 2021-04-22T08:19:13Z |
dc.date.available | 2021-04-22T08:19:13Z |
dc.date.issued | 2017-03-27 |
dc.identifier.citation | Ruiz-Ortiz E, Iglesias E, Soriano A, Buján-Rivas S, Español-Rego M, Castellanos-Moreira R, et al. Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene. Front Immunol. 2017 Mar 27;8:299. |
dc.identifier.issn | 1664-3224 |
dc.identifier.uri | https://hdl.handle.net/11351/5896 |
dc.description | Aparició en l'adult; Malalties autoinflamatòries; Variants de baixa penetrància |
dc.description.sponsorship | This study has been supported by Ministerio de Economía y Competitividad (SAF 14/57708-R) and co-funded by Fondo Europeo de Desarrollo Regional (FEDER), Unión Europea, and Una manera de hacer Europa (JH-R). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Immunology;8 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Grups d'edat |
dc.subject | Receptors cel·lulars |
dc.subject.mesh | Receptors, Tumor Necrosis Factor, Type I |
dc.subject.mesh | Age Groups |
dc.title | Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fimmu.2017.00299 |
dc.subject.decs | receptores de factores de necrosis tumoral tipo I |
dc.subject.decs | Grupos de Edad |
dc.relation.publishversion | https://www.frontiersin.org/articles/10.3389/fimmu.2017.00299/full |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ruiz-Ortiz E, Español-Rego M] Department of Immunology-CDB, Hospital Clinic, IDIBAPS, Barcelona, Spain. [Iglesias E] Pediatric Rheumatology Unit, Department of Pediatrics, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain. [Soriano A] Rheumatology Unit, Department of Internal Medicine, Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, Rome, Italy. Campus Bio-Medico University, Rome, Italy. [Buján-Rivas S] Grup de Malalties Autoimmunitàries Sistèmiques, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Castellanos-Moreira R] Clinical Unit of Autoinflammatory Diseases and Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain |
dc.identifier.pmid | 28396659 |
dc.identifier.wos | 000397450600001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2014-57708-R |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |